PATENT CLAIM ANALYSIS

Application Number: 16376053
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["424", "451000"]

Abstract:
The present invention provides compositions containing endoxifen, formulations and liposomes of endoxifen, methods of preparation of such agents and formulations, and use of such agents and formulations for the treatment of a subject having or at risk for psychiatric and neurodegenerative diseases. Specifically, the present invention relates to the composition comprising endoxifen in the treatment of bipolar disorder, schizophrenia, multiple sclerosis (MS), Alzheimer disease, Parkinson disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), and/or epilepsy by administrating formulations or compositions comprising an effective amount of endoxifen.

Claim (Index 7):
The method of  claim 6 , wherein said disease is bipolar disorder.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 100.0
- Lexical Diversity: 1.74576
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15139687', '12515261', '14382356', '15058916', '13942686']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6988468263726529
- 35 USC 102 Novelty (BERT): 0.539964626812402
- Combined Prediction Score: 0.6829586064166278
- Mean Citation Score: 235.933694
- Max Citation Score: 290.53674
- Similarity Product: 119.2310924811244

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test